Gale, Daniel P.

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin

Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R., et al. (2010) · Haematologica

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 191

Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2α mutation

Gale, D. P., Harten, S. K., Reid, C. D. L., Tuddenham, E. G. D., & Maxwell, P. H. (2008) · Blood

Erythropoietin and Anemia TreatmentPulmonary Hypertension Research and Treatments

Cited by 157

Evidence for a lack of a direct transcriptional suppression of the iron regulatory peptide hepcidin by hypoxia-inducible factors

Volke, M., Gale, D. P., Maegdefrau, U., Schley, G., Klanke, B., Bosserhoff, A.-K., Maxwell, P. H., Eckardt, K.-U., & Warnecke, C. (2009) · PLoS ONE

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 93

Cardiopulmonary function in two human disorders of the hypoxia‐inducible factor (HIF) pathway: von Hippel‐Lindau disease and HIF‐2α gain‐of‐function mutation

Formenti, F., Beer, P. A., Croft, Q. P. P., Dorrington, K. L., Gale, D. P., Lappin, T. R. J., Lucas, G. S., Maher, E. R., Maxwell, P. H., McMullin, M. F., et al. (2011) · The FASEB Journal

Cancer, Hypoxia, and MetabolismPulmonary Hypertension Research and Treatments

Cited by 92

De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures

Ito, Y., Carss, K. J., Duarte, S. T., Hartley, T., Keren, B., Kurian, M. A., Marey, I., Charles, P., Mendonça, C., Nava, C., et al. (2018) · The American Journal of Human Genetics

Genetics and Neurodevelopmental DisordersGenomics and Rare Diseases

Cited by 41

Genetic variants predisposing to an increased risk of kidney stone disease

Lovegrove, C. E., Goldsworthy, M., Haley, J., Smelser, D., Gorvin, C., Hannan, F. M., Mahajan, A., Suri, M., Sadeghi-Alavijeh, O., Moochhala, S. H., et al. (2025) · Journal of Clinical Investigation

Kidney Stones and Urolithiasis TreatmentsGenetic Associations and Epidemiology

Cited by 18

Genetic variants predisposing to increased risk of kidney stone disease

Lovegrove, C. E., Goldsworthy, M., Haley, J., Diane, S., Gorvin, C., Hannan, F. M., Mahajan, A., Mohnish, S., Sadeghi-Alavijeh, O., Moochhala, S., et al. (2024) · Journal of Clinical Investigation

Kidney Stones and Urolithiasis TreatmentsGenetic Associations and Epidemiology

Cited by 18